馬向け獣医用治療薬市場：世界の産業分析、市場規模・シェア・成長・動向、将来予測 (2025～2032年)

Persistence Market Research社はこのほど、世界の馬向け獣医用治療薬市場に関する包括的な分析を発表しました。当レポートでは、市場促進要因・動向・機会・課題などの重要な市場力学を徹底的に評価し、市場構造に関する詳細な洞察を提供しています。当レポートは、世界の馬向け獣医用治療薬市場の予測成長軌道 (2025～2032年) を概説する独占的データと統計を掲載しています。

主要な洞察

• 馬向け獣医用治療薬の市場規模 (2025年)：14億米ドル
• 市場規模の予測 (金額ベース、2032年)：23億米ドル
• 世界市場の成長率 (CAGR、2025～2032年)：6.7%

馬向け獣医用治療薬市場：分析範囲

馬向け獣医用治療薬は、馬に影響を及ぼす健康状態の予防、診断、治療に不可欠です。この市場には、馬特有のニーズに対応するよう調整された医薬品、ワクチン、栄養補助食品が含まれます。これらの治療薬は、感染症、関節障害、寄生虫感染、その他の健康問題の管理のために、獣医師、馬診療所、馬主によって広く使用されています。市場成長の原動力は、馬の健康に対する意識の高まり、馬術競技への投資の増加、獣医学の進歩です。また、馬の健康を確保するためのワクチンや栄養補助食品などの予防ケアソリューションの採用が増加していることも、市場の利益となっています。

市場成長の促進要因：

世界の馬向け獣医用治療薬市場は、疝痛、蹄葉炎、馬インフルエンザなどの馬の疾病の蔓延の増加など、いくつかの重要な要因によって推進されています。馬術スポーツやレクリエーション活動への参加者増加により、馬の健康への関心が高まり、獣医学的治療への支出が増加しています。さらに、バイオテクノロジーの進歩により、標的療法が開発され、治療効果が高まり、副作用が最小限に抑えられています。予防医療の重要性に対する馬主の意識が高まっていることも、ワクチンや栄養補助食品の需要を押し上げる重要な要因となっています。馬診療所のネットワークが拡大し、高度な診断ツールが利用可能になりつつあることも、市場の成長をさらに後押ししています。

市場抑制要因：

有望な成長が見込まれるもの、馬向け獣医用治療薬市場は、治療費の高騰、専門獣医の不足、規制上のハードルといった課題に直面しています。特に可処分所得が限られている新興国では、小規模な馬主にとって馬用医薬品やワクチンのコストは法外なものとなる可能性があります。さらに、動物用医薬品の承認と使用を管理する厳しい規制は、メーカーにコンプライアンス上の負担をもたらし、製品の上市を遅らせます。特定の療法に伴う副作用のリスクや、馬向け医療に対する保険が十分に適用されないことが、市場の成長をさらに抑制しています。

市場機会：

馬向け獣医用治療薬市場は、技術革新、都市化の進展、馬のケア基準の進化によって大きな成長機会をもたらしています。馬用のウェアラブルモニタリング装置などのデジタルヘルス技術の統合は、病気の早期発見を強化し、予防医療を促進します。さらに、新規の生物製剤や遺伝子ベースの治療法の開発により、以前は治療不可能だった疾患の治療に新たな道が開かれます。乗馬ツーリズムの人気上昇とコンパニオンアニマルの健康への注目の高まりは、市場参入企業にさらなるチャンスをもたらします。研究開発への戦略的投資と、製薬会社と乗馬団体間のコラボレーションは、市場拡大を促進すると予想されます。

当レポートで回答する主な質問

• 世界の馬向け獣医用治療薬市場の成長を促進する主な要因は何か？
• 最も需要が高い製品セグメントは何か、またその理由は何か？
• 獣医学の進歩は馬向け治療薬市場の競合情勢にどのような影響を与えているか？
• 馬向け獣医用治療薬市場の主要企業はどこか？また、市場の関連性を維持するためにどのような戦略をとっているのか？
• 世界の馬向け獣医用治療薬市場における新たな動向と将来性は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

• 市場の範囲と定義
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
  • 課題
  • 主な動向
• 医薬品のライフサイクル分析
• 馬向け獣医用治療薬市場：バリューチェーン
  • 原材料サプライヤー一覧
  • メーカー一覧
  • 販売代理店一覧
  • 用途一覧
  • 収益性分析
• ポーターファイブフォースの分析
• 地政学的緊張：市場への影響
• マクロ経済要因
  • 世界の部門別の展望
  • 世界のGDP成長の見通し
  • 世界の親市場の概要
• 予測要因：関連性と影響
• 規制と技術の情勢

第3章 世界の馬向け獣医用治療薬市場の展望：過去 (2019～2023年) と予測 (2025～2032年)

• 主なハイライト
  • 市場規模の予測 (数量ベース)
  • 市場規模と前年比成長率
  • 絶対的収益機会
• 市場規模の分析と予測 (金額ベース (10億米ドル))
  • 過去の市場規模の分析 (2019～2023年)
  • 現在の市場規模の予測 (2025～2032年)
• 世界の馬向け獣医用治療薬市場の展望：薬剤別
  • イントロダクション/主な調査結果
  • 過去の市場規模の実績：薬剤別 (金額 (10億米ドル)・数量ベース、2019～2023年)
  • 現在の市場規模の予測：薬剤別 (金額 (10億米ドル)・数量ベース、2025～2032年)
    • 抗炎症剤
    • 抗感染剤
    • 寄生虫駆除剤
    • その他
• 市場魅力分析：薬剤別
• 世界の馬向け獣医用治療薬市場の展望：投与経路別
  • イントロダクション/主な調査結果
  • 過去の市場規模の実績：投与経路別 (金額 (10億米ドル)・数量ベース、2019～2023年)
  • 現在の市場規模の予測：投与経路別 (金額 (10億米ドル)・数量ベース、2025～2032年)
    • 経口
    • 非経口
    • 局所
• 市場魅力分析：投与経路別
• 世界の馬向け獣医用治療薬市場の展望：サービス別
  • イントロダクション/主な調査結果
  • 過去の市場規模の実績：サービス別 (金額 (10億米ドル)・数量ベース、2019～2023年)
  • 現在の市場規模の予測：サービス別 (金額 (10億米ドル)・数量ベース、2025～2032年)
    • 診断検査・画像診断
    • 身体健康モニタリング
    • 手術
    • 予防接種
    • その他
• 市場魅力分析：サービス別
• 世界の馬向け獣医用治療薬市場の展望：流通チャネル別
  • イントロダクション/主な調査結果
  • 過去の市場規模の実績：流通チャネル別 (金額 (10億米ドル)・数量ベース、2019～2023年)
  • 現在の市場規模の予測：流通チャネル別 (金額 (10億米ドル)・数量ベース、2025～2032年)
    • 動物病院
    • 獣医クリニック
    • 薬局・ドラッグストア
    • eコマース
    • その他
• 市場魅力分析：流通チャネル別

第4章 世界の馬向け獣医用治療薬市場の展望：地域別

• 主なハイライト
• 過去の市場規模の分析：地域別 (金額 (10億米ドル)・数量ベース、2019～2023年)
• 現在の市場規模の予測：地域別 (金額 (10億米ドル)・数量ベース、2025～2032年)
  • 北米
  • 欧州
  • 東アジア
  • 南アジア・オセアニア
  • ラテンアメリカ
  • 中東・アフリカ
• 市場魅力分析：地域別

第5章 北米の馬向け獣医用治療薬市場の展望：過去 (2019～2023年) と予測 (2025～2032年)

第6章 欧州の馬向け獣医用治療薬市場の展望：過去 (2019～2023年) と予測 (2025～2032年)

第7章 東アジアの馬向け獣医用治療薬市場の展望：過去 (2019～2023年) と予測 (2025～2032年)

第8章 南アジア・オセアニアの馬向け獣医用治療薬市場の展望：過去 (2019～2023年) と予測 (2025～2032年)

第9章 ラテンアメリカの馬向け獣医用治療薬市場の展望：過去 (2019～2023年) と予測 (2025～2032年)

第10章 中東・アフリカの馬向け獣医用治療薬市場の展望：過去 (2019～2023年) と予測 (2025～2032年)

第11章 競合情勢

• 市場シェア分析 (2023年)
• 市場構造
  • 競合激化マップ：市場別
  • 競合ダッシュボード
  • 製品の生産能力 (見かけ値)
• 企業プロファイル (詳細：概要、財務、戦略、最近の動向)
  • Merck Animal Heath
  • Affymetrix
  • Elanco Animal Health
  • Zoetis (Pfizer Animal Health)
  • Equine Health UK

第12章 付録

• 分析手法
• 分析の前提条件
• 頭字語と略語

Persistence Market Research has recently released a comprehensive report on the worldwide market for equine veterinary therapeutics. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global equine veterinary therapeutics market from 2025 to 2032.

Key Insights:

• Equine Veterinary Therapeutics Market Size (2025E): USD 1.4 Billion
• Projected Market Value (2032F): USD 2.3 Billion
• Global Market Growth Rate (CAGR 2025 to 2032): 6.7%

Equine Veterinary Therapeutics Market - Report Scope:

Equine veterinary therapeutics are critical for the prevention, diagnosis, and treatment of health conditions affecting horses. The market includes pharmaceuticals, vaccines, and nutritional supplements tailored to address equine-specific needs. These therapeutics are extensively used by veterinarians, equine clinics, and horse owners for the management of infections, joint disorders, parasitic infestations, and other health issues. Market growth is driven by rising awareness of equine health, increasing investments in equestrian sports, and advancements in veterinary medicine. The market also benefits from the growing adoption of preventive care solutions, such as vaccines and nutritional supplements, to ensure the well-being of horses.

Market Growth Drivers:

The global equine veterinary therapeutics market is propelled by several key factors, including the increasing prevalence of equine diseases such as colic, laminitis, and equine influenza. Rising participation in equestrian sports and recreational activities has elevated the focus on horse health, leading to higher spending on veterinary care. Moreover, advancements in biotechnology have resulted in the development of targeted therapies, enhancing treatment efficacy and minimizing side effects. Another critical driver is the growing awareness among horse owners about the importance of preventive healthcare, which has boosted the demand for vaccines and nutritional supplements. The expanding network of equine clinics and the rising availability of advanced diagnostic tools further support market growth.

Market Restraints:

Despite promising growth prospects, the equine veterinary therapeutics market faces challenges related to high treatment costs, limited availability of specialized veterinarians, and regulatory hurdles. The cost of equine pharmaceuticals and vaccines can be prohibitive for small-scale horse owners, particularly in emerging economies with limited disposable income. Additionally, stringent regulations governing the approval and use of veterinary drugs create compliance burdens for manufacturers and delay product launches. The risk of adverse effects associated with certain therapies and the lack of adequate insurance coverage for equine healthcare further restrain market growth.

Market Opportunities:

The equine veterinary therapeutics market presents significant growth opportunities driven by technological innovations, increasing urbanization, and evolving equine care standards. The integration of digital health technologies, such as wearable monitoring devices for horses, enhances early disease detection and promotes preventive care. Furthermore, the development of novel biologics and gene-based therapies opens new avenues for the treatment of previously untreatable conditions. The rising popularity of equestrian tourism and the growing focus on companion animal health create additional opportunities for market players. Strategic investments in research and development, coupled with collaborations between pharmaceutical companies and equestrian organizations, are expected to drive market expansion.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the equine veterinary therapeutics market globally?
• Which product segments are experiencing the highest demand, and why?
• How are advancements in veterinary medicine influencing the competitive landscape of the equine therapeutics market?
• Who are the key players in the equine veterinary therapeutics market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global equine veterinary therapeutics market?

Competitive Intelligence and Business Strategy:

Leading players in the global equine veterinary therapeutics market, including Zoetis Inc., Merck Animal Health, and Boehringer Ingelheim, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies are investing in R&D to develop advanced therapies, including long-acting injectable drugs, biologics, and targeted treatments for chronic conditions like arthritis and laminitis. Partnerships with equine healthcare providers, equestrian associations, and veterinary schools facilitate product adoption and market penetration.

Key Companies Profiled:

• Zoetis Inc.
• Merck Animal Health
• Boehringer Ingelheim
• Elanco Animal Health
• Dechra Pharmaceuticals
• Virbac
• Ceva Sante Animale
• Vetoquinol S.A.

Equine Veterinary Therapeutics Industry Segmentation

By Drugs:

• Anti-Inflammatory
• Anti-Infective
• Parasiticides

By Route of Administration:

• Oral
• Parental
• Topical

By Services:

• Diagnostic Tests and Imaging
• Physical Health Monitoring
• Surgery
• Vaccination

By Distribution Channel:

• Veterinary Hospital
• Veterinary Clinics
• Pharmacies and drug stores
• E-commerce

By Region:

• North America
• Europe
• East Asia
• South Asia & Oceania
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Equine Veterinary Therapeutics Market Snapshot, 2025 - 2032
• 1.2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Challenges
  • 2.2.5. Key Trends
• 2.3. Drugs Lifecycle Analysis
• 2.4. Equine Veterinary Therapeutics Market: Value Chain
  • 2.4.1. List of Raw Material Supplier
  • 2.4.2. List of Manufacturers
  • 2.4.3. List of Distributors
  • 2.4.4. List of Applications
  • 2.4.5. Profitability Analysis
• 2.5. Porter Five Force's Analysis
• 2.6. Geopolitical Tensions: Market Impact
• 2.7. Macro-Economic Factors
  • 2.7.1. Global Sectorial Outlook
  • 2.7.2. Global GDP Growth Outlook
  • 2.7.3. Global Parent Market Overview
• 2.8. Forecast Factors - Relevance and Impact
• 2.9. Regulatory and Technology Landscape

3. Global Equine Veterinary Therapeutics Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 3.1. Key Highlights
  • 3.1.1. Market Volume (Units) Projections
  • 3.1.2. Market Size and Y-o-Y Growth
  • 3.1.3. Absolute $ Opportunity
• 3.2. Market Size (US$ Bn) Analysis and Forecast
  • 3.2.1. Historical Market Size Analysis, 2019 - 2023
  • 3.2.2. Current Market Size Forecast, 2025 - 2032
• 3.3. Global Equine Veterinary Therapeutics Market Outlook: Drugs
  • 3.3.1. Introduction / Key Findings
  • 3.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Drugs, 2019 - 2023
  • 3.3.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Drugs, 2025 - 2032
    • 3.3.3.1. Anti- Inflammatory
    • 3.3.3.2. Anti - Infective
    • 3.3.3.3. Parasiticides
    • 3.3.3.4. Others
• 3.4. Market Attractiveness Analysis: Drugs
• 3.5. Global Equine Veterinary Therapeutics Market Outlook: Route of Administration
  • 3.5.1. Introduction / Key Findings
  • 3.5.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Route of Administration, 2019 - 2023
  • 3.5.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Route of Administration, 2025 - 2032
    • 3.5.3.1. Oral
    • 3.5.3.2. Parental
    • 3.5.3.3. Topical
• 3.6. Market Attractiveness Analysis: Route of Administration
• 3.7. Global Equine Veterinary Therapeutics Market Outlook: Service
  • 3.7.1. Introduction / Key Findings
  • 3.7.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Service, 2019 - 2023
  • 3.7.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Service, 2025 - 2032
    • 3.7.3.1. Diagnostic Tests and Imaging
    • 3.7.3.2. Physical Health Monitoring
    • 3.7.3.3. Surgery
    • 3.7.3.4. Vaccination
    • 3.7.3.5. Others
• 3.8. Market Attractiveness Analysis: Service
• 3.9. Global Equine Veterinary Therapeutics Market Outlook: Distribution Channel
  • 3.9.1. Introduction / Key Findings
  • 3.9.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Distribution Channel, 2019 - 2023
  • 3.9.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 3.9.3.1. Veterinary Hospital
    • 3.9.3.2. Veterinary Clinics
    • 3.9.3.3. Pharmacies and drug stores
    • 3.9.3.4. E-commerce
    • 3.9.3.5. Other
• 3.10. Market Attractiveness Analysis: Distribution Channel

4. Global Equine Veterinary Therapeutics Market Outlook: Region

• 4.1. Key Highlights
• 4.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Region, 2019 - 2023
• 4.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Region, 2025 - 2032
  • 4.3.1. North America
  • 4.3.2. Europe
  • 4.3.3. East Asia
  • 4.3.4. South Asia and Oceania
  • 4.3.5. Latin America
  • 4.3.6. Middle East & Africa (MEA)
• 4.4. Market Attractiveness Analysis: Region

5. North America Equine Veterinary Therapeutics Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 5.1. Key Highlights
• 5.2. Pricing Analysis
• 5.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 5.3.1. By Country
  • 5.3.2. By Drugs
  • 5.3.3. By Route of Administration
  • 5.3.4. By Service
  • 5.3.5. By Distribution Channel
• 5.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 5.4.1. U.S.
  • 5.4.2. Canada
• 5.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Drugs, 2025 - 2032
  • 5.5.1. Anti- Inflammatory
  • 5.5.2. Anti - Infective
  • 5.5.3. Parasiticides
  • 5.5.4. Others
• 5.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Route of Administration, 2025 - 2032
  • 5.6.1. Oral
  • 5.6.2. Parental
  • 5.6.3. Topical
• 5.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Service, 2025 - 2032
  • 5.7.1. Diagnostic Tests and Imaging
  • 5.7.2. Physical Health Monitoring
  • 5.7.3. Surgery
  • 5.7.4. Vaccination
  • 5.7.5. Others
• 5.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
  • 5.8.1. Veterinary Hospital
  • 5.8.2. Veterinary Clinics
  • 5.8.3. Pharmacies and drug stores
  • 5.8.4. E-commerce
  • 5.8.5. Other
• 5.9. Market Attractiveness Analysis

6. Europe Equine Veterinary Therapeutics Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 6.1. Key Highlights
• 6.2. Pricing Analysis
• 6.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 6.3.1. By Country
  • 6.3.2. By Drugs
  • 6.3.3. By Route of Administration
  • 6.3.4. By Service
  • 6.3.5. By Distribution Channel
• 6.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 6.4.1. Germany
  • 6.4.2. France
  • 6.4.3. U.K.
  • 6.4.4. Italy
  • 6.4.5. Spain
  • 6.4.6. Russia
  • 6.4.7. Turkiye
  • 6.4.8. Rest of Europe
• 6.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Drugs, 2025 - 2032
  • 6.5.1. Anti- Inflammatory
  • 6.5.2. Anti - Infective
  • 6.5.3. Parasiticides
  • 6.5.4. Others
• 6.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Route of Administration, 2025 - 2032
  • 6.6.1. Oral
  • 6.6.2. Parental
  • 6.6.3. Topical
• 6.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Service, 2025 - 2032
  • 6.7.1. Diagnostic Tests and Imaging
  • 6.7.2. Physical Health Monitoring
  • 6.7.3. Surgery
  • 6.7.4. Vaccination
  • 6.7.5. Others
• 6.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
  • 6.8.1. Veterinary Hospital
  • 6.8.2. Veterinary Clinics
  • 6.8.3. Pharmacies and drug stores
  • 6.8.4. E-commerce
  • 6.8.5. Other
• 6.9. Market Attractiveness Analysis

7. East Asia Equine Veterinary Therapeutics Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 7.1. Key Highlights
• 7.2. Pricing Analysis
• 7.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 7.3.1. By Country
  • 7.3.2. By Drugs
  • 7.3.3. By Route of Administration
  • 7.3.4. By Service
  • 7.3.5. By Distribution Channel
• 7.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 7.4.1. China
  • 7.4.2. Japan
  • 7.4.3. South Korea
• 7.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Drugs, 2025 - 2032
  • 7.5.1. Anti- Inflammatory
  • 7.5.2. Anti - Infective
  • 7.5.3. Parasiticides
  • 7.5.4. Others
• 7.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Route of Administration, 2025 - 2032
  • 7.6.1. Oral
  • 7.6.2. Parental
  • 7.6.3. Topical
• 7.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Service, 2025 - 2032
  • 7.7.1. Diagnostic Tests and Imaging
  • 7.7.2. Physical Health Monitoring
  • 7.7.3. Surgery
  • 7.7.4. Vaccination
  • 7.7.5. Others
• 7.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
  • 7.8.1. Veterinary Hospital
  • 7.8.2. Veterinary Clinics
  • 7.8.3. Pharmacies and drug stores
  • 7.8.4. E-commerce
  • 7.8.5. Other
• 7.9. Market Attractiveness Analysis

8. South Asia & Oceania Equine Veterinary Therapeutics Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 8.1. Key Highlights
• 8.2. Pricing Analysis
• 8.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 8.3.1. By Country
  • 8.3.2. By Drugs
  • 8.3.3. By Route of Administration
  • 8.3.4. By Service
  • 8.3.5. By Distribution Channel
• 8.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 8.4.1. India
  • 8.4.2. Southeast Asia
  • 8.4.3. ANZ
  • 8.4.4. Rest of South Asia & Oceania
• 8.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Drugs, 2025 - 2032
  • 8.5.1. Anti- Inflammatory
  • 8.5.2. Anti - Infective
  • 8.5.3. Parasiticides
  • 8.5.4. Others
• 8.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Route of Administration, 2025 - 2032
  • 8.6.1. Oral
  • 8.6.2. Parental
  • 8.6.3. Topical
• 8.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Service, 2025 - 2032
  • 8.7.1. Diagnostic Tests and Imaging
  • 8.7.2. Physical Health Monitoring
  • 8.7.3. Surgery
  • 8.7.4. Vaccination
  • 8.7.5. Others
• 8.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
  • 8.8.1. Veterinary Hospital
  • 8.8.2. Veterinary Clinics
  • 8.8.3. Pharmacies and drug stores
  • 8.8.4. E-commerce
  • 8.8.5. Other
• 8.9. Market Attractiveness Analysis

9. Latin America Equine Veterinary Therapeutics Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 9.1. Key Highlights
• 9.2. Pricing Analysis
• 9.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 9.3.1. By Country
  • 9.3.2. By Drugs
  • 9.3.3. By Route of Administration
  • 9.3.4. By Service
  • 9.3.5. By Distribution Channel
• 9.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 9.4.1. Brazil
  • 9.4.2. Mexico
  • 9.4.3. Rest of Latin America
• 9.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Drugs, 2025 - 2032
  • 9.5.1. Anti- Inflammatory
  • 9.5.2. Anti - Infective
  • 9.5.3. Parasiticides
  • 9.5.4. Others
• 9.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Route of Administration, 2025 - 2032
  • 9.6.1. Oral
  • 9.6.2. Parental
  • 9.6.3. Topical
• 9.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Service, 2025 - 2032
  • 9.7.1. Diagnostic Tests and Imaging
  • 9.7.2. Physical Health Monitoring
  • 9.7.3. Surgery
  • 9.7.4. Vaccination
  • 9.7.5. Others
• 9.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
  • 9.8.1. Veterinary Hospital
  • 9.8.2. Veterinary Clinics
  • 9.8.3. Pharmacies and drug stores
  • 9.8.4. E-commerce
  • 9.8.5. Other
• 9.9. Market Attractiveness Analysis

10. Middle East & Africa Equine Veterinary Therapeutics Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 10.1. Key Highlights
• 10.2. Pricing Analysis
• 10.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 10.3.1. By Country
  • 10.3.2. By Drugs
  • 10.3.3. By Route of Administration
  • 10.3.4. By Service
  • 10.3.5. By Distribution Channel
• 10.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 10.4.1. GCC
  • 10.4.2. Egypt
  • 10.4.3. South Africa
  • 10.4.4. Northern Africa
  • 10.4.5. Rest of Middle East & Africa
• 10.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Drugs, 2025 - 2032
  • 10.5.1. Anti- Inflammatory
  • 10.5.2. Anti - Infective
  • 10.5.3. Parasiticides
  • 10.5.4. Others
• 10.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Route of Administration, 2025 - 2032
  • 10.6.1. Oral
  • 10.6.2. Parental
  • 10.6.3. Topical
• 10.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Service, 2025 - 2032
  • 10.7.1. Diagnostic Tests and Imaging
  • 10.7.2. Physical Health Monitoring
  • 10.7.3. Surgery
  • 10.7.4. Vaccination
  • 10.7.5. Others
• 10.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
  • 10.8.1. Veterinary Hospital
  • 10.8.2. Veterinary Clinics
  • 10.8.3. Pharmacies and drug stores
  • 10.8.4. E-commerce
  • 10.8.5. Other
• 10.9. Market Attractiveness Analysis

11. Competition Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. Market Structure
  • 11.2.1. Competition Intensity Mapping By Market
  • 11.2.2. Competition Dashboard
  • 11.2.3. Apparent Product Capacity
• 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 11.3.1. Merck Animal Heath
    • 11.3.1.1. Overview
    • 11.3.1.2. Segments and Product
    • 11.3.1.3. Key Financials
    • 11.3.1.4. Market Developments
    • 11.3.1.5. Market Strategy
  • 11.3.2. Affymetrix
    • 11.3.2.1. Overview
    • 11.3.2.2. Segments and Product
    • 11.3.2.3. Key Financials
    • 11.3.2.4. Market Developments
    • 11.3.2.5. Market Strategy
  • 11.3.3. Elanco Animal Health
    • 11.3.3.1. Overview
    • 11.3.3.2. Segments and Product
    • 11.3.3.3. Key Financials
    • 11.3.3.4. Market Developments
    • 11.3.3.5. Market Strategy
  • 11.3.4. Zoetis (Pfizer Animal Health)
    • 11.3.4.1. Overview
    • 11.3.4.2. Segments and Product
    • 11.3.4.3. Key Financials
    • 11.3.4.4. Market Developments
    • 11.3.4.5. Market Strategy
  • 11.3.5. Equine Health UK
    • 11.3.5.1. Overview
    • 11.3.5.2. Segments and Product
    • 11.3.5.3. Key Financials
    • 11.3.5.4. Market Developments
    • 11.3.5.5. Market Strategy

12. Appendix

• 12.1. Research Methodology
• 12.2. Research Assumptions
• 12.3. Acronyms and Abbreviations